Gain Therapeutics, Inc. (GANX)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Sep 09, 14:06
Gain Therapeutics Total Liabilities (Quarterly) : 4.130M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.130M |
| March 31, 2026 | 4.732M |
| December 31, 2025 | 4.254M |
| September 30, 2025 | 5.062M |
| June 30, 2025 | 6.138M |
| March 31, 2025 | 5.844M |
| December 31, 2024 | 4.784M |
| September 30, 2024 | 5.456M |
| June 30, 2024 | 7.411M |
| March 31, 2024 | 5.935M |
| December 31, 2023 | 6.031M |
| September 30, 2023 | 6.767M |
| June 30, 2023 | 7.168M |
| March 31, 2023 | 6.184M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.220M |
| September 30, 2022 | 5.663M |
| June 30, 2022 | 4.873M |
| March 31, 2022 | 5.771M |
| December 31, 2021 | 4.168M |
| September 30, 2021 | 5.017M |
| June 30, 2021 | 3.964M |
| March 31, 2021 | 3.577M |
| December 31, 2020 | 3.402M |
| September 30, 2020 | 1.795M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 1.110M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.42M |
| Shareholders Equity (Quarterly) | 11.29M |
| Debt to Equity Ratio | 0.054 |
| Current Ratio | 4.359 |
| Net Debt Paydown Yield | 0.00% |